Kimberly Atianzar, MD
Interventional Cardiology · Augusta, GANPI 1497917629
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,568 of the $11,915 with a category attached, or 63.5%. Medtronic accounts for 60.1% of it on its own, with 18 other manufacturers making up the rest.
Across 170 payments — averaging $70.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Abbott$2K
- Abiomed$648
- Cardiovascular Systems Inc.$632
- Boston Scientific$334
- Edwards Lifesciences$292
- plus $1K from 13 others
Across 14 payments — averaging $1071.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$15K
What the payments were for
- Speaking & faculty fees$1,50013%
- Travel & lodging$2,72623%
- Food & beverage$7,56864%
- Education$1211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 64 | $7,167 |
| Abbott | 34 | $1,787 |
| Abiomed | 10 | $648 |
| Cardiovascular Systems Inc. | 12 | $632 |
| Boston Scientific | 10 | $334 |
| Edwards Lifesciences | 9 | $292 |
| Biosense Webster, Inc. | 2 | $231 |
| W. L. Gore & Associates, Inc. | 5 | $216 |
| AstraZeneca | 4 | $165 |
| Actelion Pharmaceuticals US, Inc. | 3 | $78 |
| Terumo Medical Corporation | 1 | $67 |
| Endologix LLC | 2 | $60 |
| Novartis | 3 | $58 |
| E.r. Squibb & Sons, L.L.C. | 3 | $48 |
| Johnson & Johnson | 4 | $48 |
| Teleflex LLC | 1 | $34 |
| Amgen | 1 | $23 |
| Shockwave Medical, Inc | 1 | $15 |
| Biotronik Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CoreValve Evolut$4,255
- COREVALVE EVOLUT R$741
- MitraClip$369
- Mitra Clip system$355
- Impella$248
- Diamondback Coronary$242
- AMPLATZER Occluders$179
- MitraClip System$122
- Acunav$122
- NA$109
- Micra$103
- Coronary Orbital Atherectomy System$100
How this compares
$11,915 in reported general payments places this provider in the 65th percentile of 218 interventional cardiology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 37 | $426 |
| Atorvastatin Calcium | 12 | $171 |
| Metoprolol Succinate | 15 | $119 |
| Lisinopril | 11 | $78 |
| Prednisone | 20 | $27 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Augusta
- Charlene RohmAugusta$67K
- Musa SharkawiAugusta$30K
- Vishal AroraAugusta$22K
- William NicholsonAtlanta$1000K
- David KandzariAtlanta$982K
- Pradeep YadavAtlanta$656K
- Salvatore ManninoMarietta$275K
- Megan CoylewrightCalhoun$271K
- Paul GuichardMarietta$260K
- Adam GreenbaumAtlanta$238K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.